tiprankstipranks
bioMerieux (BMXMF)
OTHER OTC:BMXMF
US Market
BMXMF
bioMerieux
RESEARCH TOOLSreports

bioMerieux (BMXMF) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

BMXMF Analyst Ratings

Hold
7Ratings
Hold
0 Buy
6 Hold
1 Sell
Based on 7 analysts giving stock ratings to
bioMerieux
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BMXMF Stock 12 Month Forecast

Average Price Target

$85.90
▼(-19.46% Downside)
Based on 7 Wall Street analysts offering 12 month price targets for bioMerieux in the last 3 months. The average price target is $85.90 with a high forecast of $91.01 and a low forecast of $72.81. The average price target represents a -19.46% change from the last price of $106.66.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"71":"$71","142":"$142","88.75":"$88.8","106.5":"$106.5","124.25":"$124.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":91.00735999999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$91.01</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":85.90444731428572,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$85.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":72.805888,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$72.81</span>\n  </div></div>","useHTML":true}}],"tickPositions":[71,88.75,106.5,124.25,142],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83.764,84.32118153846153,84.87836307692307,85.43554461538461,85.99272615384615,86.54990769230768,87.10708923076922,87.66427076923077,88.2214523076923,88.77863384615384,89.33581538461537,89.89299692307692,90.45017846153846,{"y":91.00735999999999,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83.764,83.92864979340659,84.09329958681319,84.25794938021978,84.42259917362637,84.58724896703296,84.75189876043956,84.91654855384616,85.08119834725275,85.24584814065935,85.41049793406593,85.57514772747253,85.73979752087912,{"y":85.90444731428572,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,83.764,82.92106830769231,82.07813661538461,81.23520492307692,80.39227323076922,79.54934153846153,78.70640984615385,77.86347815384615,77.02054646153846,76.17761476923077,75.33468307692307,74.49175138461538,73.64881969230768,{"y":72.805888,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":132.941,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.797,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":141.671,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":138.342,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.439,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.751,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.856,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.131,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":109.588,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":118.555,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.692,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.624,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.764,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$91.01Average Price Target$85.90Lowest Price Target$72.81
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on BMXMF
Charles Pitman CFA
Barclays
Barclays
$102.38→$91.01
Hold
-14.68%
Downside
Reiterated
06/23/26
bioMerieux (0RUG) Receives a Hold from Barclays
Morgan Stanley Analyst forecast on BMXMF
Aisyah Noor
Morgan Stanley
Morgan Stanley
$113.76→$72.81
Sell
-31.74%
Downside
Downgraded
06/23/26
bioMerieux downgraded to Underweight from Equal Weight at Morgan StanleybioMerieux downgraded to Underweight from Equal Weight at Morgan Stanley
RBC Capital Analyst forecast on BMXMF
Natalia Webster
RBC Capital
RBC Capital
$113.76→$85.32
Hold
-20.01%
Downside
Reiterated
06/22/26
RBC Capital Reaffirms Their Hold Rating on bioMerieux (0RUG)
Deutsche Bank Analyst forecast on BMXMF
Jan Koch
Deutsche Bank
Deutsche Bank
$92.14→$88.73
Hold
-16.81%
Downside
Reiterated
06/17/26
bioMerieux price target lowered to EUR 78 from EUR 81 at Deutsche BankbioMerieux price target lowered to EUR 78 from EUR 81 at Deutsche Bank
Piper Sandler Analyst forecast on BMXMF
David Westenberg
Piper Sandler
Piper Sandler
$91.01
Hold
-14.68%
Downside
Initiated
06/11/26
bioMerieux initiated with a Neutral at Piper SandlerbioMerieux initiated with a Neutral at Piper Sandler
UBS Analyst forecast on BMXMF
Kavya Deshpande
UBS
UBS
$156.99→$91.01
Hold
-14.68%
Downside
Downgraded
06/01/26
bioMerieux (0RUG) was downgraded to a Hold Rating at UBS
J.P. Morgan Analyst forecast on BMXMF
David Adlington
J.P. Morgan
J.P. Morgan
$137.08→$81.45
Hold
-23.63%
Downside
Reiterated
04/24/26
bioMerieux price target lowered to EUR 71.60 from EUR 120.50 at JPMorganbioMerieux price target lowered to EUR 71.60 from EUR 120.50 at JPMorgan
Exane BNP Paribas Analyst forecast on BMXMF
Hugo Solvet
Exane BNP Paribas
Exane BNP Paribas
$113.76
Hold
6.66%
Upside
Downgraded
01/28/26
bioMerieux downgraded to Neutral from Outperform at BNP ParibasbioMerieux downgraded to Neutral from Outperform at BNP Paribas
Bank of America Securities Analyst forecast on BMXMF
Anna Ractliffe
Bank of America Securities
Bank of America Securities
$102.38→$130.82
Hold
22.65%
Upside
Upgraded
12/12/25
bioMerieux upgraded to Neutral from Underperform at BofAbioMerieux upgraded to Neutral from Underperform at BofA
Kepler Capital Analyst forecast on BMXMF
Maja Pataki
Kepler Capital
Kepler Capital
$159.26
Buy
49.32%
Upside
Reiterated
09/08/25
Kepler Capital Sticks to Its Buy Rating for bioMerieux (0RUG)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on BMXMF
Charles Pitman CFA
Barclays
Barclays
$102.38→$91.01
Hold
-14.68%
Downside
Reiterated
06/23/26
bioMerieux (0RUG) Receives a Hold from Barclays
Morgan Stanley Analyst forecast on BMXMF
Aisyah Noor
Morgan Stanley
Morgan Stanley
$113.76→$72.81
Sell
-31.74%
Downside
Downgraded
06/23/26
bioMerieux downgraded to Underweight from Equal Weight at Morgan StanleybioMerieux downgraded to Underweight from Equal Weight at Morgan Stanley
RBC Capital Analyst forecast on BMXMF
Natalia Webster
RBC Capital
RBC Capital
$113.76→$85.32
Hold
-20.01%
Downside
Reiterated
06/22/26
RBC Capital Reaffirms Their Hold Rating on bioMerieux (0RUG)
Deutsche Bank Analyst forecast on BMXMF
Jan Koch
Deutsche Bank
Deutsche Bank
$92.14→$88.73
Hold
-16.81%
Downside
Reiterated
06/17/26
bioMerieux price target lowered to EUR 78 from EUR 81 at Deutsche BankbioMerieux price target lowered to EUR 78 from EUR 81 at Deutsche Bank
Piper Sandler Analyst forecast on BMXMF
David Westenberg
Piper Sandler
Piper Sandler
$91.01
Hold
-14.68%
Downside
Initiated
06/11/26
bioMerieux initiated with a Neutral at Piper SandlerbioMerieux initiated with a Neutral at Piper Sandler
UBS Analyst forecast on BMXMF
Kavya Deshpande
UBS
UBS
$156.99→$91.01
Hold
-14.68%
Downside
Downgraded
06/01/26
bioMerieux (0RUG) was downgraded to a Hold Rating at UBS
J.P. Morgan Analyst forecast on BMXMF
David Adlington
J.P. Morgan
J.P. Morgan
$137.08→$81.45
Hold
-23.63%
Downside
Reiterated
04/24/26
bioMerieux price target lowered to EUR 71.60 from EUR 120.50 at JPMorganbioMerieux price target lowered to EUR 71.60 from EUR 120.50 at JPMorgan
Exane BNP Paribas Analyst forecast on BMXMF
Hugo Solvet
Exane BNP Paribas
Exane BNP Paribas
$113.76
Hold
6.66%
Upside
Downgraded
01/28/26
bioMerieux downgraded to Neutral from Outperform at BNP ParibasbioMerieux downgraded to Neutral from Outperform at BNP Paribas
Bank of America Securities Analyst forecast on BMXMF
Anna Ractliffe
Bank of America Securities
Bank of America Securities
$102.38→$130.82
Hold
22.65%
Upside
Upgraded
12/12/25
bioMerieux upgraded to Neutral from Underperform at BofAbioMerieux upgraded to Neutral from Underperform at BofA
Kepler Capital Analyst forecast on BMXMF
Maja Pataki
Kepler Capital
Kepler Capital
$159.26
Buy
49.32%
Upside
Reiterated
09/08/25
Kepler Capital Sticks to Its Buy Rating for bioMerieux (0RUG)
Stocks with the Highest Top Analyst Consensus in the General Sector
AVEXAEVEX Corp. Class A
GENBGenerate Biomedicines, Inc.
KLRAKailera Therapeutics, Inc.
HMHHMH Holding Inc. Class A
SGPSpyGlass Pharma
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering bioMerieux

3 Months
Maja PatakiKepler Capital
Success Rate
18/32 ratings generated profit
56%
Average Return
-0.48%
Copying Maja Pataki's trades and holding each position for 3 Months would result in 56.25% of your transactions generating a profit, with an average return of -0.48% per trade.
1 Year
Maja PatakiKepler Capital
Success Rate
18/32 ratings generated profit
56%
Average Return
-0.64%
Copying Maja Pataki's trades and holding each position for 1 Year would result in 56.25% of your transactions generating a profit, with an average return of -0.64% per trade.
2 Years
Maja PatakiKepler Capital
Success Rate
14/32 ratings generated profit
44%
Average Return
-3.54%
Copying Maja Pataki's trades and holding each position for 2 Years would result in 43.75% of your transactions generating a profit, with an average return of -3.54% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BMXMF Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
1
1
Buy
0
1
1
1
0
Hold
7
5
7
5
10
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
7
6
8
7
12
In the current month, BMXMF has received 1 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. BMXMF average Analyst price target in the past 3 months is 85.90.
Each month's total comprises the sum of three months' worth of ratings.

BMXMF Financial Forecast

BMXMF Earnings Forecast

Next quarter’s earnings estimate for BMXMF is $2.43 with a range of $2.31 to $2.56. The previous quarter’s EPS was $2.28. BMXMF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year BMXMF has Performed in-line its overall industry.
Next quarter’s earnings estimate for BMXMF is $2.43 with a range of $2.31 to $2.56. The previous quarter’s EPS was $2.28. BMXMF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year BMXMF has Performed in-line its overall industry.

BMXMF Sales Forecast

Next quarter’s sales forecast for BMXMF is $1.08B with a range of $1.02B to $1.12B. The previous quarter’s sales results were $2.30B. BMXMF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year BMXMF has Performed in-line its overall industry.
Next quarter’s sales forecast for BMXMF is $1.08B with a range of $1.02B to $1.12B. The previous quarter’s sales results were $2.30B. BMXMF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year BMXMF has Performed in-line its overall industry.

BMXMF Stock Forecast FAQ

What is BMXMF’s average 12-month price target, according to analysts?
Based on analyst ratings, bioMerieux’s 12-month average price target is 85.90.
    What is BMXMF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for BMXMF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is BMXMF a Buy, Sell or Hold?
        bioMerieux has a consensus rating of Hold which is based on 0 buy ratings, 6 hold ratings and 1 sell ratings.
          What is bioMerieux’s price target?
          The average price target for bioMerieux is 85.90. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $91.01 ,the lowest forecast is $72.81. The average price target represents -19.46% Decrease from the current price of $106.66.
            What do analysts say about bioMerieux?
            bioMerieux’s analyst rating consensus is a Hold. This is based on the ratings of 7 Wall Streets Analysts.
              How can I buy shares of BMXMF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.